Rob Cribb, Director of the Investigative Journalism Bureau at the Toronto Star, dives into the murky world of clinical drug trials. He reveals how financial desperation drives participants to cut corners, risking their health and the integrity of research. Cribb shares compelling insights into the life of a 'professional guinea pig' and exposes the ethical dilemmas faced amidst scant regulatory oversight from Health Canada. The discussion also highlights the alarming realities of adverse reactions that often go unreported, raising questions about drug safety for all.